Miriam O’Connor

525 total citations
19 papers, 117 citations indexed

About

Miriam O’Connor is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miriam O’Connor has authored 19 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miriam O’Connor's work include Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer survivorship and care (3 papers). Miriam O’Connor is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer survivorship and care (3 papers). Miriam O’Connor collaborates with scholars based in Ireland, Canada and Spain. Miriam O’Connor's co-authors include Paula Calvert, Anne M. Horgan, Catherine M. Kelly, Elaine M. Walsh, Suzanne M. Garland, Sepehr N. Tabrizi, Lillian M. Smyth, Glen Mola, Cecily Quinn and Niamh M. Keegan and has published in prestigious journals such as Journal of Clinical Oncology, BJOG An International Journal of Obstetrics & Gynaecology and The Oncologist.

In The Last Decade

Miriam O’Connor

16 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miriam O’Connor Ireland 7 44 37 24 23 20 19 117
Kate Ennis United Kingdom 5 29 0.7× 21 0.6× 41 1.7× 16 0.7× 15 0.8× 10 149
Emmanuelle Jacquet France 6 42 1.0× 14 0.4× 18 0.8× 27 1.2× 10 0.5× 13 83
Scott Ramsey United States 6 48 1.1× 18 0.5× 27 1.1× 56 2.4× 12 0.6× 12 158
Stephen Della‐Fiorentina Australia 9 119 2.7× 38 1.0× 21 0.9× 39 1.7× 54 2.7× 24 190
Sophie Marilier France 7 90 2.0× 26 0.7× 7 0.3× 27 1.2× 18 0.9× 13 132
Elena Trevisi Italy 7 61 1.4× 32 0.9× 21 0.9× 42 1.8× 8 0.4× 18 152
Gabriela Sousa Portugal 8 71 1.6× 32 0.9× 32 1.3× 36 1.6× 19 0.9× 35 163
L. Uwer France 6 70 1.6× 16 0.4× 15 0.6× 32 1.4× 11 0.6× 17 102
Sherif Abouelnaga Egypt 6 28 0.6× 8 0.2× 10 0.4× 22 1.0× 38 1.9× 14 155
Danielle Riley United States 5 41 0.9× 15 0.4× 9 0.4× 11 0.5× 8 0.4× 8 80

Countries citing papers authored by Miriam O’Connor

Since Specialization
Citations

This map shows the geographic impact of Miriam O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam O’Connor more than expected).

Fields of papers citing papers by Miriam O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam O’Connor. The network helps show where Miriam O’Connor may publish in the future.

Co-authorship network of co-authors of Miriam O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam O’Connor. A scholar is included among the top collaborators of Miriam O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam O’Connor. Miriam O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Keane, Fergus, Denis Evoy, James Geraghty, et al.. (2024). Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland. Current Oncology. 31(3). 1302–1310. 1 indexed citations
2.
Albanell, Joan, María Teresa Martínez, Miriam O’Connor, et al.. (2024). Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial.. Journal of Clinical Oncology. 42(16_suppl). 1028–1028.
3.
Ged, Yasser, Dara Bracken‐Clarke, Emmet Jordan, et al.. (2024). Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study. The Oncologist. 29(11). e1621–e1625.
4.
5.
Jordan, Emmet, et al.. (2023). Systemic anti-cancer therapy in older patients with gastrointestinal malignancies following comprehensive geriatric assessment: An age-based subgroup analysis.. Journal of Clinical Oncology. 41(4_suppl). 796–796. 1 indexed citations
6.
Mullally, William, John Greene, Emmet Jordan, et al.. (2022). The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors. Irish Journal of Medical Science (1971 -). 192(1). 83–87. 4 indexed citations
7.
Matthews, Tara, et al.. (2022). Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis. Current Oncology. 29(9). 6167–6176. 11 indexed citations
8.
O’Leary, Connor, et al.. (2019). Professional burnout, work patterns and career satisfaction in medical oncologists in Ireland. Irish Journal of Medical Science (1971 -). 189(2). 711–718. 7 indexed citations
10.
O’Leary, Connor, et al.. (2018). Epidermal growth factor receptor mutated oligometastatic adeno-squamous lung cancer transformation to small cell lung cancer. Oxford Medical Case Reports. 2018(10). omy078–omy078. 2 indexed citations
11.
O’Connor, Miriam, et al.. (2017). Coping with Fatigue : Caring for people with cancer. Trinity's Access to Research Output (TARA) (Trinity College Dublin).
12.
Keegan, Niamh M., et al.. (2016). Comparing attitudes of younger and older patients towards cancer clinical trials. Journal of Geriatric Oncology. 7(3). 162–168. 19 indexed citations
13.
O’Connor, Miriam, et al.. (2016). Age barrier in clinical trials: Are we truly moving forward?. Journal of Clinical Oncology. 34(4_suppl). 208–208. 1 indexed citations
14.
Smyth, Lillian M., Elaine M. Walsh, Catherine M. Kelly, et al.. (2015). Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland. Breast Cancer Research and Treatment. 153(3). 573–582. 29 indexed citations
15.
O’Connor, Miriam, Verena Murphy, Conleth G. Murphy, et al.. (2015). PO145 ICORG 13-01 ABC SURVEY: ARE WE MEETING THE NEEDS OF PATIENTS WITH ADVANCED BREAST CANCER (ABC) IN IRELAND? A NATIONWIDE SURVEY. The Breast. 24. S71–S72. 1 indexed citations
16.
Naidoo, Jarushka, et al.. (2013). An Irish breast cancer survivorship study: Are we meeting our patients' needs?. Journal of Clinical Oncology. 31(15_suppl). e20687–e20687. 5 indexed citations
17.
McCaffrey, John, John Crown, Miriam O’Connor, et al.. (2013). A comparative analysis of distant recurrence risk assessments by Oncotype DX recurrence score alone and integrated with clinicopathologic factors in early-stage breast cancer.. Journal of Clinical Oncology. 31(15_suppl). 598–598. 1 indexed citations
18.
Garland, Suzanne M., et al.. (2012). Prevalence of human papillomavirus genotypes in women with cervical cancer in Papua New Guinea. International Journal of Gynecology & Obstetrics. 117(1). 30–32. 12 indexed citations
19.
O’Connor, Miriam, et al.. (1951). PLACENTAL METASTASIS OF A BREAST CARCINOMA. BJOG An International Journal of Obstetrics & Gynaecology. 58(5). 810–811. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026